CES 2020: Premature Ejaculation Could Soon Be A Thing Of The Past With This Contraption

Wire

CES 2020: Premature Ejaculation Could Soon Be A Thing Of The Past With This Contraption

Believe it or not, premature ejaculation is one of the most common sexual issue experienced by men, with up to 30% of men said to experience premature ejaculation at some point in their lives. Who would’ve known eh? Not me that’s for sure! *laughs nervously* Jokes aside though, if you’re not exactly sure what premature ejaculation or P.E for short entails, it’s basically defined by a male orgasm within a minute of penetration.

I know what you’re thinking. It’s the same thing I was thinking when I read that. “Isn’t that normal?!” Well apparently, the answer is no. If you’ve normalized your one minute wonders, odds are, you suffer from premature ejaculation. With all the solutions we have for erectile dysfunction, you’d think that we’d have one for E.D as well, but sadly, we do not. That is, until now.

Morari is an early stage medical device company that is developing the first external device for the treatment of PE. With the company unveiling an early stage prototype at CES 2020 in Las Vegas, it’s safe to say it’s been getting some attention.

So how exactly does it work then? Well, it involves a small battery, mild electrical pulses and is a lot more subtle than you think. It’s basically a patch that employs neuromodulation to return men’s confidence in the bedroom without affecting their partner’s enjoyment of the experience either. If you want to go into detail, it’s essentially a small, wireless transdermal electric neuromodulation – or TENS – unit.

“The use of neuromodulation is a common modality that has been proven to treat a variety of different medical conditions,”

Jeff Bennett, founder of Morari Medical.

Bennett is actually a veteran in the medical device industry and relied upon a team of experts with more than 75 years of experience in the fields of urology and sexual health in order to conceptualize this wonder patch. While early signs have been extremely positive, the company wants to ensure it puts its best foot forward when rolling the patch out, which is why a commercial release is expected in 2021.